The Argenta website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.

I accept cookies from this site
 

In this section...

Services

We undertake the following types of projects across the full spectrum of therapeutic areas and on all classes of small molecule druggable targets:

  • Hit identification
  • Hit-to-lead
  • Lead optimisation
  • Assay development and screening
  • Biomarker identification and pharmacodynamics evaluation
  • Structural biology and biophysics
  • Backup series provision
  • Drug de-risking, including pharmaceutics
  • Complete drug discovery from target to clinical candidate nomination, including ‘fast follower' programmes

To enhance our internal expertise and broaden the range of our capabilities, Argenta follows an alliance model to gain access to state-of-the-art technology and capabilities for our clients.


Print to HTML

Innovation. Expertise. Delivered